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Investigating the molecular mechanisms controlling the in vivo developmental program postembryogenesis is
challenging and time consuming. However, the developmental program can be partly recapitulated in vitro by
the use of cultured embryonic stem cells (ESCs). Similar to the totipotent cells of the inner cell mass, gene
expression and morphological changes in cultured ESCs occur hierarchically during their differentiation, with
epiblast cells developing first, followed by germ layers and finally somatic cells. Combination of high
throughput -omics technologies with murine ESCs offers an alternative approach for studying developmental
processes toward organ-specific cell phenotypes. We have made an attempt to understand differentiation net-
works controlling embryogenesis in vivo using a time kinetic, by identifying molecules defining fundamental
biological processes in the pluripotent state as well as in early and the late differentiation stages of ESCs. Our
microarray data of the differentiation of the ESCs clearly demonstrate that the most critical early differentiation
processes occur at days 2 and 3 of differentiation. Besides monitoring well-annotated markers pertinent to both
self-renewal and potency (capacity to differentiate to different cell lineage), we have identified candidate mol-
ecules for relevant signaling pathways. These molecules can be further investigated in gain and loss-of-function
studies to elucidate their role for pluripotency and differentiation. As an example, siRNA knockdown of Ma-
geB16, a gene highly expressed in the pluripotent state, has proven its influence in inducing differentiation when
its function is repressed.
Introduction
Embryonic stem cells (ESCs) are derived from the innercell mass (ICM) of preimplantation embryos [1] and can
be cultured and propagated indefinitely in the pluripotent
state. ESCs can be hierarchically differentiated into special-
ized cells of the germ layers ectoderm, endoderm, and me-
soderm and, in later stages, into somatic cell types (for reviews
see Refs. [2–4]). Functional genomics technologies, such as
‘‘Omics,’’ chip-based high-throughput assays, and gene si-
lencing, so far have contributed to identify key molecules for
the pluripotent state. Key transcription factors required for
maintaining pluripotency of stem cells include Pou5f1,Nanog,
and Sox2 and other factors (for reviews see Ref. [2]). These
molecules are vital for maintaining the identity of the ICM
during mouse preimplantation development [3,5–7]. Mole-
cules stimulated via the LIF (LIFR, JAK, and STAT3), Wnt
(Wnt proteins, Fzd, LRP5/6, and GSK-3b), and bone mor-
phogenetic protein 4 (BMP4) (SMAD complexes, TGF-b, and
Id) signaling pathways with the key pluripotency transcrip-
tion factors control other genes in the core pluripotency net-
work [8] as well. Besides transcriptional regulation, epigenetic
modifications, mediation of miRNAs, and activation of cell
signaling and cell-to-cell communication do also participate in
maintenance of pluripotency. Although a number of genes
and signaling transduction networks have been identified to
regulate pluripotency, the biological mechanisms behind
stemness and pluripotency are still not completely under-
stood. Identifying key molecules involved in pluripotency
and differentiation toward germ layers and somatic cell types
1Center of Physiology and Pathophysiology, Institute of Neurophysiology, University of Cologne, Cologne, Germany.
2Stem Cell Center, Masonic Medical Research Laboratory, Utica, New York.
3Institute for Genetics, University of Cologne, Cologne, Germany.
4Institute of Computer Science, University of Tartu, Tartu, Estonia.
5Quretec Ltd., Tartu, Estonia.
6Max-Delbrueck-Center for Molecular Medicine—MDC, Berlin, Germany.
STEM CELLS AND DEVELOPMENT
Volume 21, Number 13, 2012
 Mary Ann Liebert, Inc.
DOI: 10.1089/scd.2011.0637
2471
can be useful in understanding differentiation networks
controlling embryogenesis in vivo. Embryogenesis can be
partly recapitulated by the use of cultured ESCs in vitro [2,5].
Similar to the totipotent cells of the ICM, gene expression and
morphological changes of the cultured ESCs occur hierarchi-
cally during differentiation, first developing epiblast cells and
then germ layers and finally somatic cells. Hundreds of genes
participating in different biological processes, such as differ-
entiation, proliferation, apoptosis, intercellular communica-
tion, and cell–matrix interactions, control the differentiation of
ESCs to cells to tissue-specific cells (for reviews see Refs. [2,5]).
Such biological processes are essential for normal embryonic
development in vivo (for review see Ref. [9]). In vitro models,
such as ESCs, combined with appropriate experimental pro-
tocols could allow the identification of genes participating in
differentiation processes in vivo [2,6,7]. Progressive sponta-
neous differentiation of ESCs in multicellular 3-dimensional
embryoid bodies (EBs) that results in the formation of tissue-
specific cells can be used to identify those multilineage-
decisive genes. Formation of EBs [2,3,6] is a spontaneous
anchorage-independent process. However, 3 main problems
exist toward identifying prominent biological and signal
transduction pathways for pluripotency and differentiation
using the ESCmodel. (i) The ESCmodel is extremely sensitive
to the experimental conditions and even small variations of
culture techniques as applied by different investigators will
frequently lead to different results. (ii) The onset and shut-
down of key biological differentiation processes occur in a
narrow time window. Missing of this time window results in
failing to detect or correctly interpret key biological processes.
(iii) Comprehensive omics technologies, stringent statistical
criteria, and bioinformatics analysis are necessary to get a
deep view into the complex biological processes occurring at
the different time points of the differentiation.
To overcome these complications, we used a previously
developed optimized feeder-free culturing protocol for the
CGR8 murine ESC line [2,6,7] and applied the ‘‘hanging
drop’’ protocol for obtaining EBs [2,3,6]. To cover all the
possible specific differentiation processes occurring in a
narrow window time, RNA was isolated each day until day
7 and finally at day 10 (Fig. 1) for microarray hybridization.
Stringent statistical criteria were applied to avoid false pos-
itive and false negative results.
Materials and Methods
ESC culture and EB formation
CGR8 ESCs (ECACC 95011018) were cultured without
feeder cells in Glasgow minimum essential medium sup-
plemented with 10% fetal bovine serum (FBS), 2mM l-
glutamine, 100U/mL LIF, and 50 mM b-mercaptoethanol
(ME) in 0.2% gelatine-coated flasks as previously described
[10]. CGR8 ESCs (passage No. 8) were treated with trypsin
and used for preparation of cell suspensions (25,000 cells/
mL) in Iscove’s modified Dulbecco’s minimal essential me-
dium (IMDM) (Invitrogen) supplemented with 20% FBS, 1%
non essential amino acid (NEAA) (vol/vol), 2mM l-gluta-
mine, and 100mM b-ME. For the ‘‘hanging drop’’ method,
20mL drops of this ESC suspension were placed on the inner
surface of the lid of a Petri dish (diameter: 10 cm; Greiner).
FIG. 1. Hanging drop protocol followed to generate embryoid bodies (EBs) to track the differentiation process from
embryonic stem cells (ESCs) to 10-day old EBs. Color images available online at www.liebertonline.com/scd
2472 GASPAR ET AL.
The Petri dishes that contained 5mL phosphate-buffered sa-
line (PBS) were closed with the lid and incubated under
normal culture conditions. After days 1–7 and 10, all EBs were
separately collected for RNA isolation. RNA isolation from the
10-day-old EBs was performed after the 7-day-old EBs were
plated in cultured dishes and incubated in IMDM supple-
mented with 20% FBS, 100mM b-ME, 2mM l-glutamine, and
1% NEAA (vol/vol) for 3 more days. Total RNAs from these
time points were taken for the transcriptome study.
RNA isolation and whole-genome gene expression
profiling of ESCs and EBs of time kinetic study
The experimental procedures followed for microarray
hybridization have been described previously [11]. Micro-
array data were deposited in the EBI ArrayExpress database:
www.ebi.ac.uk/arrayexpress/experiments/E-TABM-672.
Quantitative real-time–polymerase chain
reaction analysis
Validation of the Affymetrix data was performed by
quantitative real-time–polymerase chain reaction (qRT-PCR)
analysis with ABI 7500 FAST Detection System (Applied
Biosystems). One microgram of RNA from ES (day 0) and 4-,
7-, and 10-day-old EBs was reverse transcribed using Su-
perScript VILO cDNA synthesis kit (Invitrogen GmbH).
qRT-PCR was performed in triplicates for every sample using
SYBR-Green PCR Master Mix (QuantiFast qPCR Master Mix;
Qiagen). Validation has been performed for Pou5f1 (NM_
013633), Nanog (NM_028016), Mageb16 (NM_001113734), Ets
variant gene 5 (Etv5) (NM_023794), ribonuclease P25 subunit
(Rpp25) (NM_133982), and b-Actin (NM_007393) (for primer
sequences see Supplementary Table S1; Supplementary Data
are available online at www.liebertonline.com/scd). These
genes were chosen in terms of their significance in relationship
to pluripotency. All reactions were performed with the fol-
lowing conditions, beginning with Taq activation at 95C for
5min, thereafter 40 cycles of 10 s denaturation at 95C, 30 s of
combined annealing and extension at 60C, and finally ending
with a melting curve acquisition. The relative quantities of the
target genes were normalized against relative quantities of
b-actin keeping undifferentiated ESCs (day 0) as a reference
sample. Fold-expression changes were calculated by raising to
the power of the negative value of delta-delta Ct value (2-DDCT)
and the resulting values were plotted as log2 values setting the
expression value of the reference sample to 0.
siRNA knockdown
siRNAs for Mageb16 [Mm_Mageb16 (2410003J06Rik_5):
TAGGGAGAAGGGAGCGTCTTA; Mm_Mageb16 (2410003
J06Rik_6): TACGGGCTAAAGCTGAAACTA] were pur-
chased from Qiagen and used at a concentration of 5 nM.
Lipofectamine 2000 (Invitrogen) was used as siRNA trans-
fection reagent as instructed by the manufacturer. CGR8 cells
(7 · 104) seeded in 24-well plates with normal growth me-
dium (containing LIF) were transfected the following day
with siRNA-Lipofectamine complex. Negative transfection
control labeled with Alexa Flour 488 provided by Qiagen (to
monitor transfection efficiency with green fluorescence) was
used as scrambled control; mock control (transfection agent
only) also was included. After 6 h of transfection, normal
growth medium was added. Cells were harvested after 48 h
for RNA and protein isolation. Knockdown efficiency was
measured with qRT-PCR at mRNA expression level and
with western blotting at protein expression level. Expression
of the pluripotency markers Pou5f1, Nanog, and Sox2 and
early mesodermal, ectodermal, and endodermal markers
T (Brachyury), FGF5, and HNF4a, respectively, was deter-
mined in untransfected ESCs and scrambled and Mageb16-
knockdown samples using qRT-PCR. Nucleotide sequences
of these primers are provided in Supplementary Table S1.
Western blotting
Separate knockdown experiment was set with Mageb16
siRNA along with negative transfection control (scrambled)
and untransfected ESC control following the same protocol
mentioned previously in siRNA knockdown method. Cells
(4· 105) were seeded in 25 cm2 flask and the same 5nM
siRNA concentration was used. Cells were collected after
trypsinization and washed with cold PBS and lysed in
150mM NaCl, 1mM EDTA, 20mM Tris-HCl (pH 7.4), 1mM
phenylmethanesulfonyl fluoride, 1% Triton X-100, and 1%
protease inhibitor cocktail (Sigma) at 4C. Protein samples
were quantified with the Bradford reagent (Sigma). From
each sample 45mg of protein was separated using 12% so-
dium dodecyl sulfate–polyacrylamide gel electrophoresis
gels and transferred to polyvinylidene fluoride membrane.
Membranes were blocked with 5% bovine serum albumin
at room temperature. Membranes were incubated with Ma-
geb16 polyclonal antibodies (Abgent Europe Ltd.) for over-
night at 4C on orbital shaking. After washing with PBST
solution (PBS with 0.1% Tween-20), membranes were incu-
bated with secondary antibodies and labeled with horse-
radish peroxidase for 1 h at room temperature. Mageb16 was
detected using enhanced chemiluminescence Western de-
tection system (Fisher Scientific GmbH).
Identifying significantly regulated transcripts related
to pluripotency and self-renewal
Array data were quantile normalized using the RMA im-
plementation of the R Affy package [12,13]. Probe sets mar-
ginally expressed in all conditions were rejected using the
MAS5 present call (P < 0.05) [14]. Differential expression of
the remaining 23,142 of 45,101 has been determined by the
linear model implementation of the R Limma package [15]
followed by a Benjamini Hochberg multiple testing correc-
tion (1% FDR). To determine specifically regulated plur-
ipotency-associated transcripts, the expression levels of
undifferentiated ESCs (day 0) were pairwise compared with
the levels of differentiated 3- to 7-day-old EBs since many
pluripotency markers, such as Pou5f1, do not show signifi-
cantly varying expression up to day 3. Of particular interest
were transcripts that show high expression in the undiffer-
entiated state and low expression levels throughout differ-
entiation. Size of change was stated with threshold value of
fold change (FC) 2 in absolute scale.
To have a highly consistent list of significantly regulated
transcripts, intersection of significant regulated genes from
the CGR8 time course and from the transgenic experiment
cluster of CGR8 was implemented. To obtain a significant list
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of genes of the transgenic experiment cluster of CGR8, fol-
lowing transgenic cell lines of CGR8, such as a-myosin heavy
chain (a-MHC) ESCs [9], BMP2 ESCs [16], T (Brachyury)
ESCs [17], a-smooth muscle actin 2 (Acta2) ESCs [18], and
CD31 ESCs [19]), were taken for pairwise comparisons
against their corresponding mixed (multilineage) and puri-
fied populations. Clear description of the strategy followed
to obtain the significant list of genes in the transgenic ex-
periment cluster of CGR8 mentioned previously is outlined
in Fig. 2.
From the list obtained from the intersection study per-
formed, only significant transcription factors were chosen to
prove their homogeneous expression pattern both in undif-
ferentiated and differentiated states other than in CGR8 cell
lines. For that a time series of the mouse ESC lines, R1, J1,
and V6.5, dataset of an 11-point time course (Embryonic
Stem Cell and Embryoid Body Time course) study [20] made
public in Gene Expression Omnibus, was chosen.
Identifying significantly regulated transcripts
in differentiating ESCs
To avoid biased interpretation of the large number of
differentially expressed genes during differentiation of ESCs
and to identify specific gene signature pathways, we used
the gene ontology–analysis of variance (GO-ANOVA) ap-
plication of the Partek Genomic Suite version 6.4 for our
analysis. For each annotation the application sets up an
ANOVA with 3 factors: array, transcript, and as an addi-
tional parameter the time course to identify genes that follow
a particular expression pattern. GO annotations with an
FDR < 0.1% along the time course (n= 5,772 of 6,455) were
selected as differentially expressed. The selection was addi-
tionally restricted to level 5 GO annotations (n = 1,453) to
prevent overflowing overlap caused by the (multi-) hierar-
chical structure of GO. P values of consecutive points in time
were - log10 transformed and afterward normalized to a
mean of zero and a standard deviation of one. Estimation of
the number of K-means clusters using the Davies-Bouldin
procedure leads to K= 7 groups.
Principal component analysis
Principal component analysis (PCA) is performed using
Partek Genomics Suite (Partek, Inc.) to visualize data vari-
ability in a multidimensional picture. Distance between the
samples reflects the degree of dissimilarity between them.
PCA mapping of the time kinetic data shows 54.9% of data
variance in the first 3 principal components (PC1 33.6%, PC2
13.9%, and PC3 7.39%).
FIG. 2. Methodology applied to identify differentially expressed transcripts pertinent to pluripotency. Step 1: Obtained list
of differentially expressed transcripts is commonly found in all pairwise statistical comparisons between ESCs (day 0) and
day 3–7 and 10 EBs. Step 2: (a) Identified differentially expressed transcripts common to pairwise statistical comparisons
between transgenic undifferentiated ESCs and their generated mixed populations. (b) Identified differentially expressed
transcripts common to pairwise statistical comparisons between transgenic CGR8 ESC population and their generated pure
populations. Step 3: Intersection-resulted list of lists from Step 2a and b. Step 4: Intersection-resulted list of lists from Step 1
and 3, and from these, 202 upregulated transcripts and 150 downregulated transcripts are identified after redundancy
removal.
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Results and Discussion
Visualization of transcriptome alteration
at differentiation process
Early EB differentiation is characterized by fundamental
changes of the transcriptome. PCA of the differentially ex-
pressed genes resulted in 3 characteristic principal compo-
nents (PCs) that represent 54.9% of the dataset variance
(Fig. 3A, B). The 100 most correlated probe sets in component
loading of each PC [absolute (r) > 0.8] have been visualized in
a heatmap after hierarchical clustering to exemplify the
characteristic of the PCs. PC1, PC2, and PC3 represent single,
transient, and double-transient switches of the expression
status, respectively (Fig. 3C). The most prominent switch
time point in PC1 (33.6% of the dataset variance) is found
between days 3 and 4; up to day 3 there is no significant
change. Among the pluripotency-related core factors, Pou5f1
has its constant expression up to day 3 and even some of the
other pluripotency-related regulatory genes stay without
significant changes in their expression profile.
Significantly regulated transcripts pertinent
to pluripotency
Intersection of significant regulated genes in the CGR8 time
course and CGR8 transgenic experiment cluster resulted in
202 upregulated transcripts and 150 downregulated tran-
scripts after redundancy avoidance (Supplementary Tables S2
and S3).
Among 202 high-expressed transcripts, there are 60 tran-
scription factors (Supplementary Table S4) identified and so
far reported pluripotency-associated markers are all present
in these 60 genes. Among low-expressed genes, there are
26 transcription factors (Supplementary Table S5). Expres-
sion pattern wise, clear separation between high- and low-
expressed transcription factors was observed (Fig. 4) in a
time series of the mouse ESC lines R1, J1, and V6.5, when the
pattern of expression of 54 significant transcription factors
from the just outlined lists was visualized. Therefore, irre-
spective of different murine ESC lines, these identified
common transcription factors seem to have similar regula-
tory mechanism at pluripotency network.
Transcription factors prominently expressed
in the pluripotent state
Besides the well-known pluripotency-associated tran-
scription factors, such as Pou5f1, Nanog, Sox2, Kruppel-like
factor 4 (Klf4), other Klf factors—such as Klf2, Klf5, and
Utf1—Esrrb, Tcfcp21l, Sall4, Dax1 (Nr0b1), Stat4, and Zfp42,
few more regulatory genes (Table 1) were identified based
on significant changes (downexpressed) of their expression
level after the induction of differentiation. From this, only
few transcription factors, which are neither discussed well
with its pluripotency association nor taken for related ge-
netic manipulation study, are reported in the following
paragraph.
Among them, Polyhomeotic-like 1 (Phc1) is a core com-
ponent of polycomb repressive complex 1 (PRC1), a poly-
comb group protein complex that is required for maintaining
ESC pluripotency and plasticity during embryonic develop-
ment [21]. Jardi2 (jumonji, AT-rich interactive domain 2), a
factor that negatively regulates cell proliferation, is a regu-
latory subunit of PRC2. It regulates Prc2-mediated H3k27
methylation and eventually modulates ESC pluripotency
and somatic cell reprogramming due to methylation along
with other subunits of Prc2, MTF2, and esPRC2p48 [22]. Rbpj
(recombination signal binding protein for immunoglobulin
kappa J region) is involved in NOTCH signaling [23] and has
been predicted to have an important role in maintaining
pluripotency [24]. Forkhead box D3 (Foxd3) is essential for
the development of endoderm, is expressed in ESCs, and is
associated with early lineage-specific decisions with a cor-
egulatory factor Pou5f1 [25]. More recently, it has been
shown that tet oncogene 1 (Tet1) along with Tet2 is associ-
ated with the pluripotent state [26]. Regulatory factor X2
(Rfx2) that influences HLA class II expression is highly ex-
pressed in testis and is mentioned as Pou5f1-associated
protein [27]. Also, it has been shown that depletion of de-
velopmental pluripotency associated 2 (Dppa2) initiated
FIG. 3. Principal component analysis
(PCA) mapping of PCs 1 and 2 (A) and
PCs 1 and 3 (B). PCA has been done
using correlation as the dispersion
matrix and normalized eigenvector
scaling. The 100 best correlated probe
sets to each PC have been heatmap
visualized (C) after hierarchical aver-
age linkage clustering using the Eu-
clidean distance function. Color images
available online at www.liebertonline
.com/scd
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differentiation and in parallel repressed proliferation in
murine ESCs [28]. DNA methyltransferase 3-like (Dnmt3l) is
required for DNA methylation in stem cells and is not ex-
pressed in differentiating cells [29]. Monocytic leukemia zinc-
finger protein (MOZ) along with MORF (MYST4) safeguards
identity of stem cell through maintaining epigenetic integrity
[30]. In ESCs, Moz expression is regulated by the cascade of
Nanog, Pou5f1, and Sox2 [31]. Zinc finger and BTB domain
containing 8a (Zbtb8a) is predicted to be one of the tran-
scription factors having at least one preimplantation ex-
pressed sequence tag (EST) among many ESTs used to study
the 7 stages of development from the unfertilized oocyte to
the blastocyst stage [32]. Knockout studies of Etv5 have
shown its involvement in the maintenance of spermatogonial
stem cells by regulating chemokine production from Sertoli
cells [33]. Etv5 is involved in the regulation of branching
involved in mammary gland duct morphogenesis [34].
Transcription factor 15 (Tcf15) also known as Paraxis is in-
volved in paraxial mesodermal development and regulates
somite morphogenesis [35]. Tudor domain containing 12
(Tdrd12) also know as ECAT8 has been identified as one of
the candidates of the LIF/Stat3-independent factor essential
for pluripotent cells [36]. Makorin-ring finger protein
(Mkrn1) is a putative downstream gene of Pou5f1 and is
expected to play significant role at the maintenance of
pluripotency [37]. Gli family zinc finger 1 (Gli1), a Hedgehog
transcription factor, is involved in the positive regulation of
cell proliferation, osteoblast differentiation, and in epidermal
cell differentiation [38]. Rpp25 is involved in transcription
and processing of tRNA and it also binds to H1 RNA in
vitro [39]. DNA segment, Chr 1, Pasteur Institute 1 (D1Pas1)
is expressed in germ cells of the testis and its expression is
developmentally regulated [40]. However, its expression is
much higher in ESCs compared with differentiated EBs.
ATP-binding cassette, sub family B, member 1A (Abcb1a)
along with other ABC transporters, such as Abcg2, Abcb1b
and Abcc1 is expressed both in early germ cells and latter in
testis [41]. The mouse-specific Zinc finger proteins zfp936,
1700029I01Rik, zfp229, and zfp819 also are significantly
overexpressed in the undifferentiated state. However, so far
nothing is known about a potential functional role of these
zinc finger proteins for the pluripotency of the ESCs.
Highly expressed new candidate genes are critical
to the pluripotency network
The following group contains the highly upregulated
genes (Table 2) that have not yet been associated with
stemness or pluripotency properties. Mageb16, melanoma
antigen family B, that still remains functionally non-
annotated shows higher level of expression in the undiffer-
entiated state.Morc1 is located in the nucleus and is reported
to be involved in spermatogenesis [42] and in ‘‘regulation of
early meiotic prophase events involving chromosome syn-
apsis or recombination’’ and even may perturb generation of
male germ cells through meiosis [43]. Its role in cell cycle
FIG. 4. Expression pattern of significant transcription factors during progressive differentiation of the ESCs (ESCs to 10-day
old EBs). (A) R1 Embryonic Stem Cell and Embryoid Body Time Course. (B) J1 ESC and EB Time Course. (C) V6.5 Embryonic
Stem Cell and Embryoid Body Time Course. An 11-point time course study is included as time course: 0 h, 6 h, 12 h, 18 h, 24 h,
36 h, 48 h, 4 days, 7 days, 9 days, and 14 days. Color images available online at www.liebertonline.com/scd
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regulation and proliferation of NT2 embryonal carcinoma
stem cells has also been studied. Cth, also known as cy-
stathionine gamma-lyase (CSE), is involved in the negative
regulation of cell growth and proliferation. CSE-knockout
mice show increased proliferation rates of smooth muscle
cells [44]. Solute carrier family 7 (Slc7a3) is found in the
plasma membrane and is involved in amino acid transpor-
tation and the regulation of Target of rapamycin signaling
[45]. Heat shock transcription factor 2 binding protein
(Hsf2bp) is expressed in human testis and its involvement in
modulation of HSF2 activation in testis has been proposed
[46]. Gametocyte specific factor 1-like gene (Gtsf1l), mapped
at chromosome 2, is expressed at testis and is essential for
spermatogenesis beyond the early meiotic phase [47]. Lipase
member H (Liph), mapped at chromosome 3, involves in
lipid catabolic process and is found in membrane. Cordon-
bleu (Cobl) is expressed in the axial structure of the gas-
trulating mouse embryo [48] and is involved in the biological
process neural tube closure. Proteasome subunit alpha type 8
(Psma8) is involved in the positive regulation of ubiquitin-
protein ligase activity that regulates mitotic cell cycle. Its
high level of expression in testis and in murine ESCs is re-
corded at BioGPS gene annotation portal [49]. Oocyte ex-
pressed protein homolog (Ooep) (dog) is involved in in utero
embryonic development and is found in the cytosol. Its ex-
pression is higher in oocytes and has been reported to be
associated with Ces5, significantly regulated gene at murine
ESCs [50]. Leucine-rich repeat containing 34 (Lrrc34) is
highly expressed in murine ESCs and in testis. Pycard, con-
taining PYD and CARD domain, is involved in signal
transduction and regulation of the apoptosis pathway [51].
Correlation between mRNA detected
by microarrays and qRT-PCR
Verification of the homogeny of signal expression levels of
few notable genes identified from microarray data analysis
prominent at pluripotent state, such as Mageb16 (NM_001
113734), Etv5 (NM_023794), and RPP25 (NM_133982) along
with known markers Pou5f1 (NM_013633) and Nanog
(NM_028016), was performed with qRT-PCR. As indicated, in
Fig. 5A and B, results of the Affymetrix analyses clearly corre-
spond to the results obtained from the qRT-PCR. Therefore, the
list of transcripts identified is reliable. As a proof of concept,
Mageb16, prominently expressed at pluripotent state, was
chosen for knockdown study to observe the expression of ESCs
and germ layers’ marker genes.
Mageb16 knockdown activates differentiation even
in the presence of LIF
From our study, it was identified that Mageb16 mRNA
expression decreases drastically with the initiation of
Table 1. Regulatory Genes (Transcription Factors) Identified to Be Significantly
Upregulated in the Pluripotent State of Embryonic Stem Cells
Gene symbol FC (day 3) FC (day 4) FC (day 5) FC (day 6) FC (day 7) FC (day 10)
1700029I01Rik - 9.45 - 11.31 - 8.75 - 10.56 - 12.21 - 13.18
2610305D13Rik - 15.24 - 29.45 - 23.92 - 21.56 - 29.04 - 9.65
Abcb1a - 38.44 - 41.92 - 36.75 - 35.05 - 35.98 - 37.63
Dnmt3l - 27.73 - 45.25 - 49.29 - 47.29 - 46.42 - 38.68
D1Pas1 - 7.98 - 8.72 - 9.88 - 11.49 - 12.20 - 12.34
Dppa2 - 27.28 - 51.27 - 54.57 - 50.56 - 49.87 - 37.27
Enpp3 - 9.58 - 12.55 - 10.78 - 7.36 - 9.06 - 10.34
Etv5 - 2.07 - 9.78 - 7.52 - 10.78 - 10.70 - 14.22
Foxd3 - 2.39 - 2.81 - 2.73 - 2.73 - 2.97 - 2.60
Gli1 - 11.79 - 12.30 - 6.87 - 8.63 - 11.16 - 12.64
Irak3 - 3.33 - 3.47 - 3.55 - 3.97 - 2.60 - 3.29
Jarid2 - 2.91 - 4.17 - 5.62 - 5.39 - 4.69 - 4.82
Mkrn1 - 4.50 - 6.11 - 7.67 - 6.36 - 6.77 - 4.14
Mybl2 - 9.00 - 9.19 - 13.27 - 16.11 - 21.41 - 37.01
Myst4 - 7.06 - 6.02 - 4.03 - 3.20 - 3.34 - 3.46
Nkx6-3 - 4.17 - 4.38 - 4.47 - 4.76 - 4.29 - 4.44
Nr5a2 - 12.21 - 10.93 - 9.85 - 6.15 - 9.92 - 10.06
Phc1 - 2.83 - 4.41 - 5.43 - 5.13 - 5.74 - 7.16
Rbpj - 3.61 - 3.84 - 4.00 - 3.18 - 2.41 - 2.10
Rfx2 - 3.63 - 4.89 - 3.41 - 3.51 - 4.14 - 5.78
Rpp25 - 14.42 - 13.27 - 16.34 - 10.70 - 10.34 - 5.43
Tcea3 - 2.60 - 4.92 - 4.56 - 6.36 - 6.77 - 4.14
Tcf15 - 2.58 - 3.16 - 3.23 - 3.20 - 2.93 - 3.23
Tdrd12 - 6.59 - 9.19 - 11.71 - 11.88 - 11.16 - 12.64
Zbtb8a - 5.10 - 7.67 - 7.94 - 7.78 - 7.41 - 5.98
Zfp229 - 11.39 - 6.96 - 5.86 - 6.15 - 7.46 - 11.39
Zfp819 - 8.17 - 10.20 - 9.65 - 10.20 - 10.63 - 9.99
FC values in absolute scale are provided in comparison with the time point day 0.
FC, fold change; Foxd3, Forkhead box D3; Rfx2, regulatory factor X2; Dppa2, developmental pluripotency associated 2; Dnmt3l, DNA
methyltransferase 3-like; Zbtb8a, zinc finger and BTB domain containing 8a; Etv5, Ets variant gene 5; Tcf15, transcription factor 15; Tdrd12,
tudor domain containing 12; Mkrn1, makorin-ring finger protein; Gli1, Gli family zinc finger 1; Rpp25, ribonuclease P25 subunit; D1Pas1,
DNA segment, Chr 1, Pasteur Institute 1; Abcb1a, ATP-binding cassette, sub family B, member 1A.
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differentiation and its expression level is very low in somatic
cells derived from ESCs. Moreover, it was also reported to be
one of the significant gene among 782 upregulated genes in
ESCs determined by a combined study of RNA seq profile
and microarray profiles [52]. Therefore, it was selected for
siRNA knockdown to explore a possible relation to plur-
ipotency. Approximately 70% of knockdown efficiency was
achieved 48h after transfection. Compared with untransfected
(ESCs), scrambled, and mock control samples, only 30% of
Mageb16 mRNA expression was observed in siRNA-Mageb16
targeted ESCs (Fig. 6A) and the same knockdown efficiency
was confirmed at protein expression level with western blot-
ting (Fig. 6B). Mageb16 siRNA-treated cells did not show sig-
nificant expression changes of pluripotency markers, such as
Pou5f1, Nanog, and Sox2. Interestingly, almost 2-fold over-
expression of early meso-, ecto-, and endodermal lineage
markers (T Brachyury, FGF5, and HNFa) was observed in the
knockdown ESCs (Fig. 6C). These findings clearly show that
Mageb16 may also be essential for pluripotency via pathways
that are independent of classic pluripotent genes, such as
Pou5f1, Nanog, and Sox2. Even in the presence of LIF, under
pluripotent conditions, knockdown of Mageb16 resulted in an
Table 2. Transcripts Highly Upregulated at Pluripotent State
Gene symbol FC (day 3) FC (day 4) FC (day 5) FC (day 6) FC (day 7) FC (day 10)
Mageb16 - 24.19 - 32.45 - 32.60 - 34.33 - 33.75 - 31.77
Morc1 - 35.71 - 43.38 - 42.23 - 43.68 - 43.60 - 43.50
Cth - 6.80 - 26.81 - 18.89 - 21.59 - 24.95 - 28.03
Slc7a3 - 10.91 - 15.82 - 15.94 - 17.07 - 18.21 - 18.77
Hsf2bp - 19.84 - 22.05 - 23.00 - 26.87 - 24.42 - 22.57
Gtsf1l - 16.37 - 21.80 - 20.28 - 19.20 - 18.74 - 20.36
Liph - 16.53 - 18.50 - 21.43 - 20.52 - 17.07 - 17.58
Cobl - 14.47 - 17.78 - 20.24 - 21.07 - 17.45 - 17.12
Psma8 - 11.52 - 12.14 - 12.60 - 13.77 - 12.98 - 13.14
Ooep - 9.41 - 10.94 - 13.40 - 10.99 - 9.80 - 8.64
Lrrc34 - 5.84 - 9.07 - 8.40 - 8.41 - 9.61 - 17.00
Pycard - 9.96 - 14.41 - 17.96 - 17.14 - 14.11 - 12.41
FC values in absolute scale are provided in comparison with the time point day 0.
Slc7a3, solute carrier family 7; Hsf2bp, heat shock transcription factor 2 binding protein; Gtsf1l, gametocyte specific factor 1-like gene; Liph,
lipase member H; Cobl, Cordon-bleu; Psma8, proteasome subunit alpha type 8; Ooep, oocyte expressed protein homolog; Lrrc34, leucine-rich
repeat containing 34.
FIG. 5. mRNA expression of
Pou5f1, Nanog, Mageb16, Ets vari-
ant gene 5 (Etv5), and ribonuclease
P25 subunit (Rpp25) derived from
quantitative real-time–polymerase
chain reaction (qRT-PCR) (A) and
derived from microarrays (B). Re-
lative quantitation is done com-
pared with day 0 in both cases.
Color images available online at
www.liebertonline.com/scd
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FIG. 6. Expression of specific pluripotent and germ layer gene markers in Mageb16 knockdown ESCs mediated by 2
different siRNAs. (A) Knockdown efficiency of 2 different Mageb16 siRNAs through transient transfection of undifferentiated
ESCs determined by qRT-PCR {[P < 0.05 for siRNA (1) and (2) vs. scrambled (1), (2)], mock, and untransfected ESCs}. (B)
Western blot analysis showing protein expression level at untransfected, scrambled (1), and siRNA (1) samples. Protein levels
were normalized to b-actin level. Compared with scrambled, the drastic reduction of MAGEB16 protein (Mol. weight= 41
kDa) is noted in siRNA-mediated knockdown of Mageb16. (C) qRT-PCR expression levels expressed as fold changes of the
pluripotent gene markers, Pou5f1, Nanog, and Sox2, of the germ layer markers TBra (mesodermal), FGF5 (ectodermal), and
HNFa (endodermal). The expression values in untransfected ESCs were set as 100%. The expression and relative expression of
pluripotency and early lineage markers were measured at scrambled as negative control and at 2 differentMageb16 siRNAs (1
and 2). P < 0.05 for Tbra, FGF5, and HNF4 siRNA (1) and (2) treated versus scrambled and untreated ESCs. Color images
available online at www.liebertonline.com/scd
FIG. 7. K-means clustering of 1354 sig-
nificant differentially expressed level 5
gene ontology annotations using the Eu-
clidean distance function. (A) The Davies
Bouldin K estimation shows an absolute
minimum at K = 7. (B) Clustering leads to
clusters with differential expression be-
tween 1 specific consecutive time pair.
Color images available online at www
.liebertonline.com/scd
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upregulation of key genes required for the formation of the
germ-layer-specific genes. Moreover, as shown in Fig. 5A, the
expression pattern of Mageb16 is similar to that of Pou5f1 and
Nanog. Therefore, the promoting actions of Mageb16 toward
pluripotency cannot be excluded. The relationship between
Mageb16 and the key pluripotency marker genes has to be
elucidated. The subcellular localization of this protein is pre-
dicted by the Euk-mPloc 2.0 package [53] to be either in the
nucleus or in the cytoplasm.
Identification of key differentiation gene
clusters using K-means clustering pertinent
to differentiation process
The K-means clustering (Fig. 7) using the Euclidean dis-
tance function resulted in straightforward and individual
patterns of regulation between 7 of the 8 pairwise com-
parisons (Supplementary Table S6). The genes identified in
these 7 clusters are all discussed here in terms of them en-
riching GO during the differentiation process. As shown in
Supplementary Fig. S1, GO and probe set interconnections
on this stage as given for cluster 1 (EB 4 to EB 5 differences)
most probe sets are related to 1 GO annotation. Other probe
sets are in central positions in the probes set to GO network
interconnection. Probe sets have been selected as inter-
connectors if they (i) interconnect 4 or more GO annota-
tions, (ii) are itself differentially expressed (FDR < 0.1%)
with an LSD P value minimum at the time frame specified
by the GO annotation cluster (LSD P< 10- 3), and (iii) with
significantly more interconnections in the specified cluster
than in all other clusters together (Fisher’s exact test FDR <
5%). Consequently, the filter cannot map the entire picture
of CGR8 differentiation but the selected interconnectors
are interesting due to their extraordinary position and fulfill
the statistical criteria to be candidate key players in differ-
entiation.
No prominent multilineage-related differentiation
pathways noted in cluster 5 at ESCs versus
day 1 EBs comparison
As shown in Supplementary Fig. S2 (part 1), 7 genes have
been identified participating in 317 GO annotations in total.
However, as indicated in the ArrayExpress Archive (www
.ebi.ac.uk/arrayexpress, ID: E-TABM-672), size of change in
expression (FC) between days 0 and 1 was relatively low
except for 7 genes: Prdx2, Nnat, Tia1, and Psmd9 (2- to 4-fold
upregulated); Stat5a, RenbP, and Hexb (4- to 9-fold down-
regulated). From these results no significant conclusions can
be made in terms of prominent differentiation pathways.
Early developmental processes are defined
by the genes in cluster 4 (day 2 vs. day 3
EB comparison)
Interestingly, we identified in cluster 4 (day 2 vs. day 3
EBs) (Supplementary Fig. S2, part 1) 15 genes that are highly
upregulated and interconnecting to 295 GOs participating
mainly in early developmental processes such as the for-
mation of the germ layers as well as on the development of
derivative somatic cells. Among the genes are the key tran-
scription factors T (Brachyury), FoxC1, FoxC2, FoxA2, HoxB1,
LHX1, and Gata4. Clearly, in day 3 EBs, transcripts partici-
pating in the early differentiation processes of all 3 germ
layers are predominantly expressed. The FOXC1, FOXC2,
and FOXA2 genes belong to the forkhead family of tran-
scription factors. FOXC1 and FOXC2 have been implicated in
the regulation of many developmental processes, including
foregut morphogenesis, proper lens formation, and hair fol-
licle development (reviewed by Refs. [54–56]). FOXC1 and
FOXC2 are expressed in the paraxial mesoderm and somites
[57–59]. Knockout homozygous mutant mice for Foxc1 -/ -/
Foxc2 -/- lack expression of segmentation genes that are
normally transcribed in anterior and posterior somites and
somites fail to express the myogenic marker MyoD [60]. In
summary several studies indicate that expression of Foxc1
and Foxc2 is crucial for the establishment of paraxial meso-
derm, leading to skeletal myogenesis in the developing
embryo [54].
Foxa2 regulates the specification, neurogenesis, and dif-
ferentiation of dopamine neurons in the midbrain floor plate
(for review see Ref. [61]). Further, it has been demonstrated
that Foxa2 is also involved in the liver development in mouse
[62]. Foxa2 and Gata4, highly expressed, act also as markers
for definitive endoderm [63].
Lhx1 is expressed during embryogenesis in the mouse
early in mesodermal tissue, and then later during urogenital
kidney, liver, and nervous system development. Also, Lhx1 is
required for regulating the vertebrate head development and
the nervous system, as well as the female reproductive tract
development (for review see Ref. [64]). The prototype
T-box transcription factor T (brachyury) is a canonical mar-
ker for early mesoderm [65]. HoxB1 belongs to the homeobox
family of genes encoding for a highly conserved family of
transcription factors and are involved in developmental
processes in all multicellular organisms. Altered segmental
identity and abnormal migration of motor neurons in mice
lack Hoxb. Lack of Hoxbi in Hoxb1-null mice demonstrated an
important role for hindbrain patterning and development
[66,67]. Hoxb1 expression is not limited to the developing
hindbrain but occurs also in the paraxial mesoderm and
cervical somites [67] as well as in the development of the
vertebrate skeleton [68]. Hoxb1 controls cell fate specification
and proliferative capacity of neural stem and progenitor cells
in ESCs [69]. Taking into consideration all these findings it is
obvious that the differentiation time point of days 2 to 3
defines the onset of the early differentiation processes.
Significant transcripts identified in day 3 versus day
4 EB comparisons, part of cluster 6
In cluster 6 (day 3 vs. day 4 EBs) (Supplementary Fig. S2,
part 1), we identified only 3 genes, TGF-b, Col1a1, and
ATP7a, that are highly upregulated and interconnecting to
277 GOs participating mainly to early developmental pro-
cesses of the vasculature development, keratinocyte differ-
entiation hematopoiesis (TGF-b), cartilage and epidermis
development, bone trabecula formation, skeletal system
morphogenesis, central nervous system neuron develop-
ment, and limb morphogenesis. Based on mouse knockout
and mutant analysis it has been demonstrated that TGF-b
signaling plays an important role in the development of
mesoderm formation, including the development of their or-
gan derivatives such as heart, bone development, and keratin
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development, as well as in endoderm formation, including
organ derivatives such as liver and gastrointestinal tract de-
velopment (for review see Ref. [70]). COL1A1 encodes for the
pro-alpha1 chains of type I collagen, the fibril-forming colla-
gen found in most connective tissues that is abundant in
bone, cornea, dermis, and tendon (for review see Ref. [71]).
The copper-translocating ATP7A is involved in the Cu2+ ho-
meostasis and in the biosynthetic incorporation of Cu into
copper-dependent enzymes that are essential for the secretory
pathway, Cu detoxification via Cu efflux, and mutations in
ATP7 are associated with Menkes disease [72,73].
Insulin-like growth factor 1 is the prominent
transcript in day 4 versus day 5 EB comparison
(cluster 1)
In cluster 1 (day 4 vs. day 5 EBs), only insulin-like growth
factor 1 (IGF1) has been identified as highly upregulated and
participating into 136 GOs (Supplementary Fig. S2, part 1).
IGF1 plays a central role in the growth and development of
many tissues in the body and seems to be a key regulator of
skeletal muscle development and repair [74]. Recently, mu-
tations in human IGF1 gene and transgenic animal studies
demonstrate that IGF1 plays an important role in the etiology
of growth retardation [75]. IGF1 network with 6 GO anno-
tations is provided in Supplementary Fig. S2 (part 1).
Onset of cardiomyocyte differentiation and blood
cell development
In cluster 2 (day 5 vs. day 6 EBs), 8 highly expressed in-
terconnecting genes participating to 101 GOs have been
identified associated with contractile structure proteins of the
heart Myh6 (myosin, heavy chain 6, cardiac muscle), Myl2
(myosin, light chain 2), Ttn (Titin), Mybpc3 (myosin binding
protein C, cardiac), and others (Supplementary Fig. S2, part 2).
These data clearly show that cardiomyocyte differentiation
started between days 5 and 6. In cluster 3, 4 expressed inter-
connecting genes participating in 79 GOs have been identified
associated with blood cell development and development of
the immune response system: Ptprc, Igh-6, Fas, and Fcer1g.
Genes identified at day 7 versus day 10
comparison, part of cluster 7
In cluster 7, 13 expressed interconnecting genes partici-
pating to 248 GOs have been identified associated with
general biological processes that are not associated with
developmental processes (Supplementary Fig. S2, part 2).
Interestingly, among them we found that CD83 antigen is
highly upregulated. CD83 is a lectin that regulates the den-
dritic cells (DCs) [76] and the lymphocyte maturation and
activation [77]. Fcgr (Fcgamma Receptors) is inflammatory
immune system mediator protein located in the plasma
membrane of leukocytes and eliciting the effects of immu-
noglobulin G antibodies on leukocytes resulting in an acti-
vation of the immune system [78]. Interestingly, Fcgr3 and
Fcgr2b are highly upregulated in between 7- and 10-day EBs.
Also, Anxa1 has been found to be remarkably upregu-
lated. AnxA1 and other annexins, such as AnxA6 and AnxA8,
are Ca2 + -binding proteins that show differences in their
subcellular localization and mode of action. It has been
shown that annexins are involved in the regulation of the
EGF receptor activity via controlling the endocytic transport
of the EGF receptor [79]. Recently, it has been shown that
Annexin A1 plays a pivotal anti-inflammatory role in innate
immunity and if it is absent inflammation is persisting.
Therefore, Annexin A1 and its G protein-coupled receptor
act as a target for anti-inflammatory therapeutics [80]. More
recently, using AnxA1-KO mice it has been demonstrated
that AnxA1 has pro-angiogenic functions for vascular endo-
thelial cell sprouting, wound healing, and tumor growth and
metastasis [81].
From our findings we may conclude that the develop-
mental/differentiation processes in ESCs are hierarchical and
reflect the ongoing of these processes under in vivo condi-
tions. Moreover, our study also contributes to the under-
standing of the mechanisms involved in the pluripotency
and differentiation of ESCs. In this context, the candidate
genes that are prominently expressed at the pluripotent state
other than well-reported genes can be considered for genetic
manipulation to elucidate their participation into plur-
ipotency network. This strategy has been demonstrated by the
knockdown of Mageb16. We also suggest that a consequential
application of this strategy may significantly accelerate the
generation of knowledge required for a stem-cell-based ther-
apy and an effective drug discovery.
Acknowledgments
This work was supported by a grant from the European
Community (6th Framework Programme, Thematic Priority:
Life sciences, genomics and biotechnology for health, Con-
tract No: FunGenES LSHG-CT-2003-503494). We would like
to thank Mr. James Mosedale, Abgent Europe Ltd., for sup-
plying us with Mageb16 polyclonal antibodies (sale order
S11072703W).
Author Disclosure Statement
No competing financial interests exist.
References
1. Evans MJ and MH Kaufman. (1981). Establishment in cul-
ture of pluripotential cells from mouse embryos. Nature
292:154–156.
2. Niwa H. (2007). How is pluripotency determined and
maintained? Development 134:635–646.
3. Loebel DAF, CMWatson, A De Young and PPL Tam. (2003).
Lineage choice and differentiation in mouse embryos and
embryonic stem cells. Dev Biol 264:1–14.
4. Chambers I, D Colby, M Robertson, J Nichols, S Lee, S
Tweedie and A Smith. (2003). Functional expression cloning
of Nanog, a pluripotency sustaining factor in embryonic
stem cells. Cell 113:643–655.
5. Avilion AA, SK Nicolis, LH Pevny, L Perez, N Vivian and R
Lovell-Badge. (2003). Multipotent cell lineages in early
mouse development depend on SOX2 function. Genes Dev
17:126–140.
6. Niwa H, J Miyazaki and AG Smith. (2000). Quantitative
expression of Oct-3/4 defines differentiation, dedifferentia-
tion or self-renewal of ES cells. Nat Genet 24:372–376.
7. Scholer HR, S Ruppert, N Suzuki, K Chowdhury and P
Gruss. (1990). New type of pou domain in germ line-specific
protein Oct-4. Nature 344:435–439.
GENE EXPRESSION SIGNATURES EMBRYONIC STEM CELLS 2481
8. Okita K and S Yamanaka. (2006). Intracellular signaling
pathways regulating pluripotency of embryonic stem cells.
Curr Stem Cell Res Ther 1:103–111.
9. Doss MX, J Winkler, SH Chen, R Hippler-Altenburg, I So-
tiriadou, M Halbach, K Pfannkuche, HM Liang, H Schulz,
et al. (2007). Global transcriptome analysis of murine em-
bryonic stem cell-derived cardiomyocytes. Genome Biol 8:
R56.
10. Gissel C, C Voolstra, MX Doss, CI Koehler, J Winkler, J
Hescheler and A Sachinidis. (2005). An optimized embry-
onic stem cell model for consistent gene expression and
developmental studies—a fundamental study. Thromb
Haemost 94:719–727.
11. Schulz H, R Kolde, P Adler, I Aksoy, K Anastassiadis, M
Bader, N Billon, H Boeuf, PY Bourillot, et al. (2009). The
FunGenES database: a genomics resource for mouse em-
bryonic stem cell differentiation. PLoS One 4:e6804.
12. Gautier L, L Cope, BM Bolstad and RA Irizarry. (2004).
affy—analysis of Affymetrix GeneChip data at the probe
level. Bioinformatics 20:307–315.
13. Irizarry RA, BM Bolstad, F Collin, LM Cope, B Hobbs and
TP Speed. (2003). Summaries of Affymetrix GeneChip probe
level data. Nucleic Acids Res 31:e15.
14. Pepper SD, EK Saunders, LE Edwards, CL Wilson and CJ
Miller. (2007). The utility of MAS5 expression summary and
detection call algorithms. BMC Bioinformatics 8:273.
15. Smyth GK. (2004). Linear models and empirical bayes
methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol 3:Article3.
16. Doss MX, S Chen, J Winkler, R Hippler-Altenburg, M
Odenthal, C Wickenhauser, S Balaraman, H Schulz, O
Hummel, et al. (2007). Transcriptomic and phenotypic
analysis of murine embryonic stem cell derived BMP2( + )
lineage cells: an insight into mesodermal patterning. Gen-
ome Biol 8:R184.
17. Doss MX, V Wagh, H Schulz, M Kull, R Kolde, K Pfann-
kuche, T Nolden, H Himmelbauer, J Vilo, J Hescheler and A
Sachinidis. (2010). Global transcriptomic analysis of murine
embryonic stem cell-derived brachyury plus (T) cells. Genes
Cells 15:209–228.
18. Potta SP, HM Liang, K Pfannkuche, J Winkler, SH Chen, MX
Doss, K Obernier, N Kamisetti, H Schulz, et al. (2009).
Functional characterization and transcriptome analysis of
embryonic stem cell-derived contractile smooth muscle cells.
Hypertension 53:196–204.
19. Mariappan D, J Winkler, SH Chen, H Schulz, J Hescheler
and A Sachinidis. (2009). Transcriptional profiling of
CD31( + ) cells isolated from murine embryonic stem cells.
Genes Cells 14:243–260.
20. Hailesellasse SK, CJ Porter, G Palidwor, C Perez-Iratxeta,
EM Muro, PA Campbell, MA Rudnicki and MA Andrade-
Navarro. (2007). Gene function in early mouse embryonic
stem cell differentiation. BMC Genomics 8:85.
21. Boyer LA, K Plath, J Zeitlinger, T Brambrink, LA Medeiros,
TI Lee, SS Levine, M Wernig, A Tajonar, et al. (2006). Poly-
comb complexes repress developmental regulators in mu-
rine embryonic stem cells. Nature 441:349–353.
22. ZhangZ,AJones,CWSun,CLi,CWChang,HYJoo,QADai,MR
Mysliwiec, LC Wu, et al. (2011). PRC2 complexes with JARID2,
MTF2, and esPRC2p48 in ES cells to modulate ES cell plur-
ipotency and somatic cell reprograming. Stem Cells 29:229–240.
23. Hori K, J Cholewa-Waclaw, Y Nakada, SM Glasgow, T
Masui, RM Henke, H Wildner, B Martarelli, TM Beres, et al.
(2008). A nonclassical bHLH-Rbpj transcription factor com-
plex is required for specification of GABAergic neurons in-
dependent of Notch signaling. Genes Dev 22:166–178.
24. Mason MJ, GP Fan, K Plath, Q Zhou and S Horvath. (2009).
Signed weighted gene co-expression network analysis of
transcriptional regulation in murine embryonic stem cells.
BMC Genomics 10:327.
25. Guo Y, R Costa, H Ramsey, T Starnes, G Vance, K Ro-
bertson, M Kelley, R Reinbold, H Scholer and R Hromas.
(2002). The embryonic stem cell transcription factors Oct-4
and FoxD3 interact to regulate endodermal-specific pro-
moter expression. Proc Natl Acad Sci U S A 99:3663–3667.
26. Walter J. (2011). An epigenetic Tet a Tet with pluripotency.
Cell Stem Cell 8:121–122.
27. Pardo M, B Lang, L Yu, H Prosser, A Bradley, MM Babu and
J Choudhary. (2010). An expanded Oct4 interaction network:
implications for stem cell biology, development, and disease.
Cell Stem Cell 6:382–395.
28. Du JA, TJ Chen, X Zou, B Xiong and GX Lu. (2010). Dppa2
knockdown-induced differentiation and repressed prolifer-
ation of mouse embryonic stem cells (vol 147, pg 265, 2010). J
Biochem (Tokyo) 147:929.
29. Ooi SKT, D Wolf, O Hartung, S Agarwal, GQ Daley, SP Goff
and TH Bestor. (2010). Dynamic instability of genomic
methylation patterns in pluripotent stem cells. Epigenetics
Chromatin 3:17.
30. Yang XJ and M Ullah. (2007). MOZ and MORF, two large
MYSTic HATs in normal and cancer stem cells. Oncogene
26:5408–5419.
31. Boyer LA, TI Lee, MF Cole, SE Johnstone, SS Levine, JR
Zucker, MG Guenther, RM Kumar, HL Murray, et al. (2005).
Core transcriptional regulatory circuitry in human embry-
onic stem cells. Cell 122:947–956.
32. Guo GJ, M Huss, GQ Tong, CY Wang, LL Sun, ND Clarke
and P Robson. (2010). Resolution of cell fate decisions re-
vealed by single-cell gene expression analysis from zygote to
blastocyst. Dev Cell 18:675–685.
33. Simon L, GC Ekman, T Garcia, K Carnes, Z Zhang, T Mur-
phy, KM Murphy, RA Hess, PS Cooke and MC Hofmann.
(2010). ETV5 regulates sertoli cell chemokines involved in
mouse stem/progenitor spermatogonia maintenance. Stem
Cells 28:1882–1892.
34. Chotteau-Lelievre A, R Montesano, J Soriano, P Soulie, X
Desbiens and Y de Launoit. (2003). PEA3 transcription fac-
tors are expressed in tissues undergoing branching mor-
phogenesis and promote formation of duct-like structures by
mammary epithelial cells in vitro. Dev Biol 259:241–257.
35. Burgess R, A Rawls, D Brown, A Bradley and EN Olson.
(1996). Requirement of the paraxis gene for somite formation
and musculoskeletal patterning. Nature 384:570–573.
36. Mitsui K, Y Tokuzawa, H Itoh, K Segawa, M Murakami, K
Takahashi, M Maruyama, M Maeda and S Yamanaka.
(2003). The homeoprotein Nanog is required for mainte-
nance of pluripotency in mouse epiblast and ES cells. Cell
113:631–642.
37. Wang L, A Zheng, L Yi, CR Xu, MX Ding and HK Deng.
(2004). Identification of potential nuclear reprogramming
and differentiation factors by a novel selection method for
cloning chromatin-binding proteins. Biochem Biophys Res
Commun 325:302–307.
38. Vestergaard J, A Lind-Thomsen, MW Pedersen, HO Jarmer,
M Bak, L Hasholt, N Tommerup, Z Tumer and LA Larsen.
(2008). GLI1 is involved in cell cycle regulation and prolif-
eration of NT2 embryonal carcinoma stem cells. DNA Cell
Biol 27:251–256.
2482 GASPAR ET AL.
39. Reiner R, N Alfiya-Mor, M Berrebi-Demma, D Wesolowski,
S Altman and N Jarrous. (2011). RNA binding properties of
conserved protein subunits of human RNase P. Nucleic
Acids Res 39:5704–5714.
40. Session DR, GS Lee and DJ Wolgemuth. (2001). Character-
ization of D1Pas1, a mouse autosomal homologue of the
human AZFa region DBY, as a nuclear protein in sper-
matogenic cells. Fertil Steril 76:804–811.
41. Scaldaferri ML, S Fera, L Grisanti, M Sanchez, M Stefanini,
M De Felici and E Vicini. (2011). Identification of side pop-
ulation cells in mouse primordial germ cells and prenatal
testis. Int J Dev Biol 55:209–214.
42. Inoue N, KD Hess, RW Moreadith, LL Richardson, MA
Handel, ML Watson and AR Zinn. (1999). New gene family
defined by MORC, a nuclear protein required for mouse
spermatogenesis. Hum Mol Genet 8:1201–1207.
43. WatsonML, AR Zinn, N Inoue, KDHess, J Cobb, MAHandel,
R Halaban, CC Duchene, GM Albright and RW Moreadith.
(1998). Identification of morc (microrchidia), a mutation that
results in arrest of spermatogenesis at an early meiotic stage in
the mouse. Proc Natl Acad Sci U S A 95:14361–14366.
44. Yang GD, LY Wu, S Bryan, N Khaper, S Mani and R Wang.
(2010). Cystathionine gamma-lyase deficiency and overpro-
liferation of smooth muscle cells. Cardiovasc Res 86:487–495.
45. Gao HJ, GY Wu, TE Spencer, GA Johnson and FW Bazer.
(2009). Select nutrients in the ovine uterine lumen. III. Ca-
tionic amino acid transporters in the ovine uterus and peri-
implantation conceptuses. Biol Reprod 80:602–609.
46. Yoshima T, T Yura and H Yanagi. (1998). Novel testis-
specific protein that interacts with heat shock factor 2. Gene
214:139–146.
47. Yoshimura T, S Toyoda, S Kuramochi-Miyagawa, T Miya-
zaki, S Miyazaki, F Tashiro, E Yamato, T Nakano and J
Miyazaki. (2009). Gtsf1/Cue110, a gene encoding a protein
with two copies of a CHHC Zn-finger motif, is involved in
spermatogenesis and retrotransposon suppression in murine
testes. Dev Biol 335:216–227.
48. Gasca S, DP Hill, J Klingensmith and J Rossant. (1995).
Characterization of a gene trap insertion into a novel gene,
cordon-bleu, expressed in axial structures of the gastrulating
mouse embryo. Dev Genet 17:141–154.
49. Wu C, C Orozco, J Boyer, M Leglise, J Goodale, S Batalov,
CL Hodge, J Haase, J Janes, JW Huss, III and AI Su. (2009).
BioGPS: an extensible and customizable portal for querying
and organizing gene annotation resources. Genome Biol
10:R130.
50. Tashiro F, M Kanai-Azuma, S Miyazaki, M Kato, T Tanaka, S
Toyoda, EYamato,HKawakami, TMiyazaki and JIMiyazaki.
(2010). Maternal-effect gene Ces5/Ooep/Moep19/Floped is
essential for oocyte cytoplasmic lattice formation and em-
bryonic development at thematernal-zygotic stage transition.
Genes Cells 15:813–828.
51. Mhyre AJ, AM Marcondes, EY Spaulding and HJ Deeg.
(2009). Stroma-dependent apoptosis in clonal hematopoietic
precursors correlates with expression of PYCARD. Blood
113:649–658.
52. Ouyang Z, Q Zhou and WH Wong. (2009). ChIP-Seq of
transcription factors predicts absolute and differential gene
expression in embryonic stem cells. Proc Natl Acad Sci U S A
106:21521–21526.
53. Chou KC and HB Shen. (2008). Cell-PLoc: a package of Web
servers for predicting subcellular localization of proteins in
various organisms. Nat Protoc 3:153–162.
54. Savage J, A Voronova, V Mehta, F Sendi-Mukasa and IS
Skerjanc. (2010). Canonical Wnt signaling regulates Foxc1/2
expression in P19 cells. Differentiation 79:31–40.
55. Ang SL and J Rossant. (1994). Hnf-3-beta is essential for
node and notochord formation in mouse development. Cell
78:561–574.
56. Hong HK, JK Noveroske, DJ Headon, T Liu, MS Sy, MJ
Justice and A Chakravarti. (2001). The winged helix/fork-
head transcription factor Foxq1 regulates differentiation of
hair in satin mice. Genesis 29:163–171.
57. Swiderski RE, RS Reiter, DY Nishimura, WLM Alward, JW
Kalenak, CS Searby, EM Stone, VC Sheffield and JJC Lin.
(1999). Expression of the Mf1 gene in developing mouse
hearts: implication in the development of human congenital
heart defects. Dev Dyn 216:16–27.
58. Winnier GE, L Hargett and BLM Hogan. (1997). The winged
helix transcription factor MFH1 is required for proliferation
and patterning of paraxial mesoderm in the mouse embryo.
Genes Dev 11:926–940.
59. Hiemisch H, AP Monaghan, G Schutz and KH Kaestner.
(1998). Expression of the mouse Fkh1/Mf1 and Mfh1 genes
in late gestation embryos is restricted to mesoderm deriva-
tives. Mech Dev 73:129–132.
60. Kume T, KY Deng and BLM Hogan. (2000). Murine fork-
head/winged helix genes Foxc1 (Mf1) and Foxc2 (Mfh1) are
required for the early organogenesis of the kidney and uri-
nary tract. Development 127:1387–1395.
61. Arenas E. (2008). Foxa2: the rise and fall of dopamine neu-
rons. Cell Stem Cell 2:110–112.
62. Lee CS, JR Friedman, JT Fulmer and KH Kaestner. (2005).
The initiation of liver development is dependent on Foxa
transcription factors. Nature 435:944–947.
63. Mora-Castilla S, JR Tejedo, A Hmadcha, GM Cahuana, F
Martin, B Soria and FJ Bedoya. (2010). Nitric oxide repres-
sion of Nanog promotes mouse embryonic stem cell differ-
entiation. Cell Death Differ 17:1025–1033.
64. Hunter C and S Rhodes. (2005). LIM-homeodomain genes in
mammalian development and human disease. Mol Biol Rep
32:67–77.
65. Wardle FC and VE Papaioannou. (2008). Teasing out
T-box targets in early mesoderm. Curr Opin Genet Dev 18:
418–425.
66. Studer M, A Lumsden, L ArizaMcNaughton, A Bradley and
R Krumlauf. (1996). Altered segmental identity and abnor-
mal migration of motor neurons in mice lacking Hoxb-1.
Nature 384:630–634.
67. Studer M, A Gavalas, H Marshall, L Ariza-McNaughton,
FM Rijli, P Chambon and R Krumlauf. (1998). Genetic in-
teractions between Hoxa1 and Hoxb1 reveal new roles in
regulation of early hindbrain patterning. Development
125:1025–1036.
68. Buckley RR and R Krumlauf. (2007). Contribution of Hoxb1
to the development of the vertebrate skeleton. Dev Biol 306:
883–893.
69. Gouti M and A Gavalas. (2008). Hoxb1 controls cell fate
specification and proliferative capacity of neural stem and
progenitor cells. Stem Cells 26:1985–1997.
70. Kitisin K, T Saha, T Blake, N Golestaneh, M Deng, C Kim, Y
Tang, K Shetty, B Mishra and L Mishra. (2007). Tgf-Beta
signaling in development. Sci Stke 2007:cm1.
71. Basel D and RD Steiner. (2009). Osteogenesis imperfecta:
recent findings shed new light on this once well-understood
condition. Genet Med 11:375–385.
GENE EXPRESSION SIGNATURES EMBRYONIC STEM CELLS 2483
72. Veldhuis N, A Gaeth, R Pearson, K Gabriel and J Camakaris.
(2009). The multi-layered regulation of copper translocating
P-type ATPases. Biometals 22:177–190.
73. Lalioti V, G Muruais, Y Tsuchiya, D Pulido and IV Sandoval.
(2009). Molecular mechanisms of copper homeostasis. Front
Biosci 14:4878–4903.
74. Barton ER. (2006). The ABCs of IGF-I isoforms: impact on
muscle hypertrophy and implications for repair. Appl Phy-
siol Nutr Metab 31:791–797.
75. Klammt J, R Pfaffle, H Werner and W Kiess. (2008). IGF
signaling defects as causes of growth failure and IUGR.
Trends Endocrinol Metab 19:197–205.
76. Erbacher A, F Gieseke, R Handgretinger and I Muller.
(2009). Dendritic cells: functional aspects of glycosylation
and lectins. Hum Immunol 70:308–312.
77. Breloer M and B Fleischer. (2008). CD83 regulates lympho-
cyte maturation, activation and homeostasis. Trends Im-
munol 29:186–194.
78. Willcocks LC, KGC Smith and MR Clatworthy. (2009). Low-
affinity Fc gamma receptors, autoimmunity and infection.
Expert Rev Mol Med 11:e24.
79. Grewal T and C Enrich. (2009). Annexins—modulators
of EGF receptor signalling and trafficking. Cell Signal 21:
847–858.
80. Perretti M and J Dalli. (2009). Exploiting the Annexin A1
pathway for the development of novel anti-inflammatory
therapeutics. Br J Pharmacol 158:936–946.
81. Yi M and JE Schnitzer. (2009). Impaired tumor growth,
metastasis, angiogenesis and wound healing in annexin
A1-null mice. Proc Natl Acad Sci U S A 106:17886–
17891.
Address correspondence to:
Prof. Agapios Sachinidis
Center of Physiology and Pathophysiology
Institute of Neurophysiology
University of Cologne
Robert Koch Str. 39
Cologne 50931
Germany
E-mail: a.sachinidis@uni-koeln.de
Received for publication November 13, 2011
Accepted after revision March 15, 2012
Prepublished on Liebert Instant Online March 15, 2012
2484 GASPAR ET AL.
